Sykehuset Buskerud   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Drammen Norway

Organization Overview

First Clinical Trial
2001
NCT00257790
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Sykehuset Buskerud HF

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Anemia, Iron-Deficiency (Phase 3)

Dementia (Phase 4)

Depression, Postpartum (Phase 3)

Neutropenia (Phase 4)

Puerperal Disorders (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 8